Core Viewpoint - Cerevel Therapeutics Holdings, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its stock offering and the subsequent acquisition by AbbVie Inc. [1][3] Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes shareholders who sold or held shares during this timeframe [2]. - Shareholders are encouraged to register for the class action by June 3, 2025, to potentially be appointed as lead plaintiffs [4]. Group 2: Allegations Against Cerevel - The lawsuit claims that Cerevel's October 16, 2023, secondary stock offering omitted critical information about AbbVie's interest in acquiring the company at a significantly higher price than the offering price of $22.81 per share [3]. - Bain Capital, Cerevel's controlling shareholder, allegedly acquired shares at an artificially low price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a profit exceeding $120 million when AbbVie announced the acquisition at $45 per share [3]. Group 3: Legal Representation - The Gross Law Firm is representing the shareholders in this class action, emphasizing its commitment to protecting investors' rights against deceitful business practices [5].

NEW YORK, April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA). Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ibotta-loss-submission-form/?id=144675&from=4 CLASS PERIOD: This lawsuit is on behalf of p ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which may have artificially deflated the stock price prior to a merger announcement with AbbVie Inc. [1][4] Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes shareholders who sold or held shares during this timeframe [3]. - Shareholders are encouraged to register for the class action by June 3, 2025, to potentially be appointed as lead plaintiffs [5]. Group 2: Allegations Against Cerevel - The complaint alleges that Cerevel's October 16, 2023, secondary stock offering omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share [4]. - Bain Capital, Cerevel's controlling shareholder, allegedly acquired shares at an artificially depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share [4]. Group 3: Legal Representation - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights and ensuring companies adhere to responsible business practices [6].

Core Viewpoint - Canopy Growth Corporation is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its financial performance and cost management during the specified class period [3]. Group 1: Allegations - The lawsuit claims that Canopy incurred significant costs related to the production of Claybourne pre-rolled joints during its product launch in Canada [3]. - It is alleged that these costs, along with indirect costs from Storz & Bickel vaporizer devices, negatively impacted the company's gross margins and overall financial results [3]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and downplaying issues related to gross margins, leading to misleading public statements [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as May 30, 2024, to February 6, 2025 [3]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline set for June 3, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

NEW YORK, April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Perpetua Resources Corp. (NASDAQ: PPTA).Shareholders who purchased shares of PPTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/perpetua-resources-corp-loss-submission-form/?id=143828&from=4CLASS PERIOD: Apr ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Skyworks Solutions, Inc. regarding a class action lawsuit due to alleged misleading statements about the company's expected revenue for fiscal year 2025, leading to a significant drop in stock price following disappointing financial results [1][2]. Group 1: Allegations and Financial Impact - The allegations state that defendants provided investors with material information about Skyworks' expected revenue, expressing confidence in the company's mobile business expansion and investment in new technologies [1]. - On February 5, 2025, Skyworks announced lower-than-expected revenue guidance for Q2 FY2025, attributing this to an intensified competitive landscape, resulting in a stock price decline from $87.08 to $65.60, a drop of over 24% in one day [1]. Group 2: Class Action Details - The class period for the lawsuit is from July 30, 2024, to February 5, 2025, and shareholders are encouraged to register for participation by May 5, 2025 [2]. - Registered shareholders will receive updates through portfolio monitoring software, and there is no cost or obligation to participate in the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - The article discusses a class action lawsuit against Ultra Clean Holdings, Inc. (NASDAQ: UCTT) due to allegations of misleading statements regarding demand for its products in the Chinese market, leading to significant stock price decline [2][3]. Group 1: Allegations and Impact - The lawsuit claims that Ultra Clean's executives provided investors with overly positive information about demand from Chinese OEMs and the domestic market, including reports of revenue doubling without signs of slowing down [2]. - It is alleged that while making these positive statements, the company concealed material adverse facts, such as facing a customer ramp issue and inventory and demand corrections, which ultimately led to weakness in demand in China [2]. - Following the release of the fourth quarter and full year 2024 fiscal results on February 24, 2025, the company acknowledged "demand softness" in China, resulting in a dramatic stock price drop from $36.06 to $25.90 per share, a decline of over 28% in one day [2]. Group 2: Class Action Details - Shareholders who purchased UCTT shares between May 6, 2024, and February 24, 2025, are encouraged to register for the class action, with a deadline of May 23, 2025, to seek lead plaintiff status [3]. - Registered shareholders will receive updates through portfolio monitoring software regarding the case's progress, and participation in the case incurs no cost or obligation [3]. Group 3: Law Firm Background - The Gross Law Firm, which is leading the class action, is recognized for protecting investors' rights against deceit and fraud, aiming to ensure companies adhere to responsible business practices [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which impacted the stock price prior to a merger announcement with AbbVie Inc. [1][2] Group 1: Allegations and Impact - Cerevel's October 16, 2023 secondary stock offering documents allegedly omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share, which artificially deflated Cerevel's stock price until the merger was announced [2] - Bain Capital, Cerevel's controlling shareholder, reportedly acquired shares at the depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [2] - Cerevel's January 18, 2024 Proxy statement is claimed to have misled investors regarding the nature and timing of AbbVie's interest in the company [2] Group 2: Class Action Details - The class period for the lawsuit includes shareholders who sold or disposed of Cerevel stock from October 11, 2023, to August 1, 2024, and those who held shares as of January 8, 2024, entitled to vote on the merger [1] - The deadline for shareholders to register for the class action is June 3, 2025, and there is no cost or obligation to participate [3] - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3] Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [4] - The firm seeks recovery for investors who incurred losses from misleading statements or omissions that led to artificial inflation of stock prices [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Atkore Inc. regarding a class action lawsuit alleging anticompetitive practices, specifically price-fixing of PVC Pipes, which led to misleading statements about the company's financial health and operations [1]. Group 1: Allegations and Impact - The complaint alleges that Atkore engaged in a price-fixing scheme that artificially inflated the price of PVC Pipes [1]. - Atkore reportedly gained significant and unsustainable financial benefits from this anticompetitive conduct [1]. - As the price-fixing scheme was exposed, the ability to maintain inflated prices resulted in a substantial decrease in PVC Pipe prices, negatively impacting Atkore's business and operations [1]. - The positive statements made by Atkore regarding its business and prospects were claimed to be materially false and misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is from August 2, 2022, to February 3, 2025, and shareholders are encouraged to register for participation [1][2]. - The deadline for shareholders to seek lead plaintiff status is April 23, 2025, and there is no cost or obligation to participate in the case [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Elastic N.V. regarding a class action lawsuit due to alleged misleading statements and operational disruptions affecting sales during FY 2025 [1]. Group 1: Allegations - The complaint alleges that Elastic made materially false and misleading statements and failed to disclose significant changes to its sales operations, particularly in the Americas [1]. - These changes reportedly disrupted Elastic's sales operations in the first quarter of FY 2025, leading to an overstatement of the stability of its sales operations [1]. - As a result, Elastic is unlikely to meet its previously issued revenue guidance for FY 2025, making the defendants' public statements materially false and misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is from May 31, 2024, to August 29, 2024, and shareholders are encouraged to register for participation [2]. - The deadline for shareholders to seek lead plaintiff status is April 14, 2025, and there is no cost or obligation to participate in the case [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].